EquitiesAmerica.com
Educational content — not investment advice

Abbott Laboratories

ABTNYQHealthcare
Visit Website

Data as of April 18, 2026

Key Metrics

Market Cap

$168.40B

P/E Ratio

27.15

P/B Ratio

3.23

Dividend Yield

2.64%

Return on Equity

Debt / Equity

26.79

Insider Ownership

0.54%

Institutional Own.

81.99%

Employees

115,000

Sector & Industry

Sector

Healthcare

Industry

Medical Devices

About Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also provides laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion serology testing; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; and drug and alcohol test. In addition, the company offers pediatric and adult nutritional products and infant formula; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. The company also provides cancer screening and diagnostic test products. The company was formerly known as Abbott Alkaloidal Company and changed its name to Abbott Laboratories in 1915. Abbott Laboratories was founded in 1888 and is based in Abbott Park, Illinois.

Ownership Snapshot

Insider0.54%
Institutional81.99%
Public / Other17.47%

Source: Yahoo Finance / SEC filings. For full details, see the Holdings page.

Explore More

Disclaimer: All data on this page is historical and sourced from publicly available databases including SEC EDGAR and Yahoo Finance. EquitiesAmerica.com is an educational publisher and does not provide personalized investment guidance, securities analysis, or trading recommendations. Past data does not predict future results. Please consult a registered investment professional before making any financial decision. Read full disclaimer.